JPWO2023086864A5 - - Google Patents
Info
- Publication number
- JPWO2023086864A5 JPWO2023086864A5 JP2024527763A JP2024527763A JPWO2023086864A5 JP WO2023086864 A5 JPWO2023086864 A5 JP WO2023086864A5 JP 2024527763 A JP2024527763 A JP 2024527763A JP 2024527763 A JP2024527763 A JP 2024527763A JP WO2023086864 A5 JPWO2023086864 A5 JP WO2023086864A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate
- oligonucleotide
- tfr1
- optionally
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278993P | 2021-11-12 | 2021-11-12 | |
| US202163278882P | 2021-11-12 | 2021-11-12 | |
| US63/278,993 | 2021-11-12 | ||
| US63/278,882 | 2021-11-12 | ||
| US202263312633P | 2022-02-22 | 2022-02-22 | |
| US202263312617P | 2022-02-22 | 2022-02-22 | |
| US63/312,633 | 2022-02-22 | ||
| US63/312,617 | 2022-02-22 | ||
| PCT/US2022/079604 WO2023086864A1 (en) | 2021-11-12 | 2022-11-10 | Muscle targeting complexes for treating facioscapulohumeral muscular dystrophy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024546436A JP2024546436A (ja) | 2024-12-24 |
| JP2024546436A5 JP2024546436A5 (https=) | 2025-11-18 |
| JPWO2023086864A5 true JPWO2023086864A5 (https=) | 2025-11-18 |
Family
ID=86336621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527763A Pending JP2024546436A (ja) | 2021-11-12 | 2022-11-10 | 顔面肩甲上腕筋ジストロフィーを処置するための筋標的化複合体およびそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250025570A1 (https=) |
| EP (1) | EP4429711A1 (https=) |
| JP (1) | JP2024546436A (https=) |
| KR (1) | KR20240099448A (https=) |
| CA (1) | CA3234136A1 (https=) |
| IL (1) | IL312170A (https=) |
| WO (1) | WO2023086864A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| EP3829595A4 (en) | 2018-08-02 | 2022-08-24 | Dyne Therapeutics, Inc. | MUSCLE-DIRECTED COMPLEXES AND USES THEREOF IN THE TREATMENT OF DYSTROPHINOPATHIES |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| US20220193250A1 (en) | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| IL309936A (en) | 2021-07-09 | 2024-03-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of dystrophinopathy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US20250339553A1 (en) | 2022-04-15 | 2025-11-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and formulations for treating myotonic dystrophy |
| AU2024299328A1 (en) | 2023-07-21 | 2026-01-22 | Marrow Therapeutics, Inc. | Hematopoietic cell targeting conjugates and related methods |
| WO2025259503A1 (en) * | 2024-06-12 | 2025-12-18 | Dyne Therapeutics, Inc. | Biomarkers for facioscapulohumeral muscular dystrophy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012024535A2 (en) * | 2010-08-18 | 2012-02-23 | Fred Hutchinson Cancer Research Center | Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd) |
| US20220193250A1 (en) * | 2018-08-02 | 2022-06-23 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| AU2021206234A1 (en) * | 2020-01-10 | 2022-09-01 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
-
2022
- 2022-11-10 KR KR1020247019054A patent/KR20240099448A/ko active Pending
- 2022-11-10 CA CA3234136A patent/CA3234136A1/en active Pending
- 2022-11-10 IL IL312170A patent/IL312170A/en unknown
- 2022-11-10 JP JP2024527763A patent/JP2024546436A/ja active Pending
- 2022-11-10 US US18/708,815 patent/US20250025570A1/en active Pending
- 2022-11-10 EP EP22893831.2A patent/EP4429711A1/en active Pending
- 2022-11-10 WO PCT/US2022/079604 patent/WO2023086864A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023086864A5 (https=) | ||
| IL312170A (en) | Muscle targeting complexes for treating facioscapulohumeral muscular dystrophy | |
| JP2021533200A5 (https=) | ||
| JP2021533197A5 (https=) | ||
| IL317871A (en) | Muscle targeting complexes and their uses for the treatment of FACIOSCAPULOHUMERAL muscular dystrophy | |
| JP2021532832A5 (https=) | ||
| JP2025067909A5 (https=) | ||
| JP2021533199A5 (https=) | ||
| Böhme et al. | Molecular cloning and nucleotide sequence analysis of the gene coding for heterocyst ferredoxin from the cyanobacterium Anabaena sp. strain PCC 7120 | |
| Nishikura et al. | Substrate specificity of the dsRNA unwinding/modifying activity. | |
| IL309910A (en) | Muscle targeting complexes and their uses for the treatment of myotonic dystrophy | |
| JPWO2020028864A5 (https=) | ||
| JP3330595B2 (ja) | ウィルス（ｈｉｖ）増殖抑制 | |
| JP2007529224A5 (https=) | ||
| JPWO2020028841A5 (https=) | ||
| JPWO2021142227A5 (https=) | ||
| JPWO2020028861A5 (https=) | ||
| JPWO2021142275A5 (https=) | ||
| CN119183457A (zh) | 用于治疗强直性肌营养不良的肌肉靶向复合物和制剂 | |
| JPWO2022026152A5 (https=) | ||
| JPWO2023283531A5 (https=) | ||
| JP2008220366A (ja) | 修飾型ｐｎａ／ｒｎａ複合体 | |
| JPWO2020028840A5 (https=) | ||
| JPWO2021142307A5 (https=) | ||
| JPWO2022147207A5 (https=) |